Detalhe da pesquisa
1.
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.
Mol Ther
; 31(3): 616-630, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635967
2.
Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019.
J Infect Dis
; 228(5): 542-554, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166076
3.
Higher Levels of Cerebrospinal Fluid and Plasma Neurofilament Light in Human Immunodeficiency Virus-Associated Distal Sensory Polyneuropathy.
Clin Infect Dis
; 76(6): 1103-1109, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310512
4.
The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
J Med Virol
; 95(11): e29216, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988251
5.
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
J Infect Dis
; 225(10): 1741-1749, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301540
6.
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
Clin Infect Dis
; 74(11): 2010-2019, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453519
7.
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment.
J Neurovirol
; 28(3): 438-445, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674935
8.
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 224(11): 1839-1848, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677601
9.
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
J Infect Dis
; 224(9): 1581-1592, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740057
10.
Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates.
Antimicrob Agents Chemother
; 65(12): e0121621, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570651
11.
Prognostic significance of MEOX2 in gliomas.
Mod Pathol
; 32(6): 774-786, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659268
12.
Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
J Pathol
; 246(2): 205-216, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30009411
13.
Epistasis and Pleiotropy Affect the Modularity of the Genotype-Phenotype Map of Cross-Resistance in HIV-1.
Mol Biol Evol
; 33(12): 3213-3225, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27678053
14.
Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
J Virol
; 90(2): 768-79, 2016 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512081
15.
Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds.
PLoS Pathog
; 11(3): e1004722, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25798934
16.
Recombination accelerates adaptation on a large-scale empirical fitness landscape in HIV-1.
PLoS Genet
; 10(6): e1004439, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24967626
17.
Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.
J Antimicrob Chemother
; 70(2): 405-11, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25281399
18.
Exploring the complexity of the HIV-1 fitness landscape.
PLoS Genet
; 8(3): e1002551, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22412384
19.
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.
BMC Bioinformatics
; 15: 77, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646213
20.
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
PLoS Pathog
; 8(7): e1002832, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910833